Blood Cancer UK Project Grants fund clearly defined research projects that address key questions in blood cancers and align with the charity’s strategy of improving survival and quality of life. The 2025–2026 call supports discovery and preclinical translational work, with scope for small clinical components where justified. This is substantial medium-term project funding aimed at established groups and rising leaders in UK blood cancer research.
Eligibility Criteria:
-
Principal investigator based at a UK university, NHS trust, or recognised research institution
-
Project focused on blood cancers (leukemia, lymphoma, myeloma, and related disorders) and clearly aligned with Blood Cancer UK’s research strategy
-
Appropriate track record and environment to deliver the proposed work
-
Co-applicants and collaborators may be UK or international, as per scheme rules
-
Full compliance with UK research governance and ethics regulations
Funding Details:
-
Maximum award: up to 300,000 GBP
-
Grant term: up to 3 years
-
Supports PI and staff salaries, consumables, animal work, sequencing/omics, and other directly incurred research costs
-
Primarily for discovery and preclinical translational research; limited, well-justified clinical components are allowed within budget and timeline
Deadline:
-
Call opens: November 6, 2025
-
Application deadline: February 5, 2026, 3:00 PM (UK time)
-
Outcomes communicated: July 2026
Where to go for further information:
-
Blood Cancer UK Apply for funding – Project Grants page